Instituto de Microbiologia Paulo de Góes da Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
J Clin Microbiol. 2013 Jul;51(7):2388-90. doi: 10.1128/JCM.00640-13. Epub 2013 Apr 24.
β-Lactam susceptibility of 499 Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae, determined by reference broth microdilution, demonstrated that 14.4% of isolates were categorized as cefepime susceptible according to current CLSI breakpoints. Ceftazidime- and meropenem-susceptible isolates were also observed (2.6 and 3.0%, respectively). Cefepime-susceptible KPC-producing isolates may confuse laboratory staff and clinicians in their therapeutic choices.
499 株产碳青霉烯酶肺炎克雷伯菌(KPC)肠杆菌科细菌的β-内酰胺类药物敏感性,采用参考肉汤微量稀释法进行检测,根据现行 CLSI 折点标准,14.4%的分离株被归类为头孢吡肟敏感。还观察到头孢他啶和亚胺培南敏感的分离株(分别为 2.6%和 3.0%)。产头孢吡肟敏感的 KPC 分离株可能会在治疗选择方面混淆实验室工作人员和临床医生。